Safety and Efficacy of Adalimumab in Pediatric Patients With Crohn Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of Adalimumab in Pediatric Patients With Crohn Disease

Published:2008-07 Issue:1 Volume:47 Page:19-25
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Wyneski Matthew J,Green Alex,Kay Marsha,Wyllie Robert,Mahajan Lori

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology and Child Health

Reference27 articles.

1. Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab;Papadakis;Am J Gastroenterol,2005

2. Medical treatment of inflammatory bowel diseases;Van;Curr Opin Gastroenterol,2005

3. Adalimumab in patients with Crohn's disease: safety and efficacy in an open-label single centre study;Seiderer;Aliment Pharmacol Ther,2001

4. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial;Hanauer;Gastroenterology,2006

5. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial;Sandborn;Gut,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab in Pediatric Inflammatory Bowel Disease;Frontiers in Pediatrics;2022-04-13

2. Vaccines in Children with Inflammatory Bowel Disease: Brief Review;Vaccines;2021-05-11

3. Biological therapy in pediatric age;Pharmacological Research;2020-11

4. Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience;Biologics: Targets and Therapy;2019-01

5. Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn;Anales de Pediatría;2018-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3